Adverse events and renal function were monitored in patients receiving CPAP and those receiving usual care.
In patients with mild cognitive impairment, there is an association between obstructive sleep apnea and beta-amyloid levels.
Watching a tape of themselves struggling to sleep increases CPAP adherence in patients with OSA.
Researchers simultaneously examined overnight polysomnography and patch recordings to determine the efficacy of the SomnaPatch.
Nearly 37% of patients with hypoventilation were diagnosed with uncontrolled hypothyroidism, and were more likely to present with hypertension and heart failure.
Treatment with CPAP doesn't doesn't reduce risk of cardiovascular related outcomes.
Apnea-hypopnea index concluded that hematocrit levels and presene of erthrocytosis are not associated with OSA.
A patient developed Stevens-Johnson Syndrome following armodafinil therapy for daytime sleepiness.
It is unknown what the clinical impact of positive airway pressure in patients with pulmonary embolism
OSA is associated with sight-threatening diabetic retinopathy in patients with type 2 diabetes; preliminary evidence suggests CPAP reduces retinopathy.
Research presented at SLEEP 2017 suggests that dronabinol, previously used to treat chemotherapy-induced nausea and vomiting, may be an effective treatment for sleep apnea.
From 1993 to 2011 there is an increased number of documented visits for SA by specials and a decreased number of visits by primary care providers.
Three in 4 study participants had sleep apnea, but only 2.1% of those cases were diagnosed.
Risk for serious pregnancy complications, length of hospital stay, and intensive care unit admission are higher in in women with obstructive sleep apnea.
Obstructive sleep apnea increases patients' risk for recurrent pulmonary embolism following cessation of oral anticoagulation therapy.
Two studies examined the link between open-heart surgery and postoperative atrial fibrillation.
The American Heart Association panel found that sleep disorders are associated with adverse cardiometabolic risk profiles and outcomes.
Although patients in the CPAP group experienced improvements in quality of life, the therapy had no significant effects on the composite end point of death from any cardiovascular cause, MI, stroke, or hospitalization for various cardiovascular events.